Pain-free microneedle influenza vaccine is effective, long-lasting

Scientists have developed an influenza vaccine delivered via microneedle patch that provided 100 percent protection against a lethal influenza virus in mice more than one year after vaccination. They report their findings in the September 2013 issue of the journal…

Scientists have developed an influenza vaccine delivered via microneedle patch that provided 100 percent protection against a lethal influenza virus in mice more than one year after vaccination. They report their findings in the September 2013 issue of the journal Clinical and Vaccine Immunology.

Microneedles are a medium for delivery of influenza vaccine that avoids the pain associated with ordinary hypodermic needles. They are a mere seven tenths of a millimeter in length, and the volume of vaccine — a major contributor to pain — is minuscule.

Instead of a liquid containing whole killed or attenuated virus, this vaccine uses dry virus-like particles (VLPs) which simply coat the needles in the presence of a simple stabilizing agent, reducing the need for refrigeration — a potential boon for use in developing countries. The lower dose required when using microneedles also reduces the potential for side effects, such as lung inflammation.

“This method can induce higher levels of IgG2a antibodies as well as rapid recall immune responses following lethal challenge infection. Our previous study showed that microneedle vaccination induced higher levels of antibody-secreting cells in spleen and bone marrow compared to intramuscular vaccination,” says Sang-Moo Kang of Georgia State University, a researcher on the study.

Earlier studies by this group showed that influenza VLP-coated microneedles actually produced higher short-term protection than conventional intramuscular immunization. In this study the researchers tested how effective the long-term protection of the vaccine was. Mice that received the vaccine were 100 percent protected from a lethal challenge with the influenza virus 14 months after vaccination.
Kang says his aim was to develop an easier and pain-free method of vaccine delivery. He also says that patients could probably use this system to vaccinate themselves.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is based on materials provided by American Society for Microbiology.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:
F.-S. Quan, Y.-C. Kim, J.-M. Song, H. S. Hwang, R. W. Compans, M. R. Prausnitz, S.-M. Kang. Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch. Clinical and Vaccine Immunology, 2013; 20 (9): 1433 DOI: 10.1128/CVI.00251-13

Note: If no author is given, the source is cited instead.

Search ScienceDaily
Number of stories in archives: 142,135

 

Interested in ad-free access? If you’d like to read ScienceDaily without ads, let us know!

more breaking science news

Social Networks
Follow ScienceDaily on Facebook, Twitter, and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

Breaking News
… from NewsDaily.com

more science news
In Other News …
more top news
Science Video News

Faster Flu Vaccine
Spraying viral genes directly through the skin is a new technique that turns infinitesimal amounts of DNA into an effective vaccine. If approved for. …  > full story

Strange Science News
Free Subscriptions
… from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:
Email Newsletters
RSS Newsfeeds
Feedback
… we want to hear from you!

Tell us what you think of ScienceDaily — we welcome both positive and negative comments. Have any problems using the site? Questions?
Leave Feedback